학술논문

Tetrandrine protects mouse retinal ganglion cells from ischemic injury
Document Type
Report
Source
Drug Design, Development and Therapy. January 1, 2014, Vol. 8, p327, 13 p.
Subject
United States
China
Language
English
ISSN
1177-8881
Abstract
This study aimed to determine the protective effects of tetrandrine (Tet) on murine ischemia-injured retinal ganglion cells (RGCs). For this, we used serum deprivation cell model, glutamate and hydrogen peroxide ([H.sub.2][O.sub.2])-induced RGC-5 cell death models, and staurosporine-differentiated neuron-like RGC-5 in vitro. We also investigated cell survival of purified primary-cultured RGCs treated with Tet. An in vivo retinal ischemia/reperfusion model was used to examine RGC survival after Tet administration 1 day before ischemia. We found that Tet affected RGC-5 survival in a dose- and time-dependent manner. Compared to dimethyl sulfoxide treatment, Tet increased the numbers of RGC-5 cells by 30% at 72 hours. After 48 hours, Tet protected staurosporine-induced RGC-5 cells from serum deprivation-induced cell death and significantly increased the relative number of cells cultured with 1 mM [H.sub.2][O.sub.2] (P Keywords: RGC-5, serum deprivation, glaucoma, mitochondrial membrane potential, apoptosis
Introduction Tetrandrine (Tet) is a bisbenzylisoquinoline alkaloid extracted from the root of the Chinese herb creeper Stephania tetrandra. (1,2) It is a calcium channel blocker (3,4) that inhibits lipid peroxidation5 [...]